E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer

Entinostat mechanism of action. Entinostat impacts cancer not only through its epigenetic actions but also through epigenetic-independent mechanisms by acetylation of non-histone protein